{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:14:18Z","timestamp":1791900858653,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,6,4]],"date-time":"2006-06-04T00:00:00Z","timestamp":1149379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/ng1814","type":"journal-article","created":{"date-parts":[[2006,6,4]],"date-time":"2006-06-04T14:01:59Z","timestamp":1149429719000},"page":"801-806","source":"Crossref","is-referenced-by-count":210,"title":["Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease"],"prefix":"10.1038","volume":"38","author":[{"given":"Mark I","family":"Rees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-Kyung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C","family":"Duguid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail E","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlea","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Shiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim J","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer M","family":"Zuberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B P","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A J","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arn M J M","family":"van den Maagdenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor G","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Supplisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,6,4]]},"reference":[{"key":"BFng1814_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ng1293-351","volume":"5","author":"R Shiang","year":"1993","unstructured":"Shiang, R. et al. Mutations in the \u03b11 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat. Genet. 5, 351\u2013358 (1993).","journal-title":"Nat. Genet."},{"key":"BFng1814_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ana.410380115","volume":"38","author":"R Shiang","year":"1995","unstructured":"Shiang, R. et al. Mutational analysis of familial and sporadic hyperekplexia. Ann. Neurol. 38, 85\u201391 (1995).","journal-title":"Ann. Neurol."},{"key":"BFng1814_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s004390100569","volume":"109","author":"MI Rees","year":"2001","unstructured":"Rees, M.I. et al. Compound heterozygosity and nonsense mutations in the \u03b11-subunit of the inhibitory glycine receptor in hyperekplexia. Hum. Genet. 109, 267\u2013270 (2001).","journal-title":"Hum. Genet."},{"key":"BFng1814_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/hmg\/11.7.853","volume":"11","author":"MI Rees","year":"2002","unstructured":"Rees, M.I. et al. Hyperekplexia associated with compound heterozygote mutations in the \u03b2-subunit of the human inhibitory glycine receptor (GLRB). Hum. Mol. Genet. 11, 853\u2013860 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1814_CR5","doi-asserted-by":"publisher","first-page":"24688","DOI":"10.1074\/jbc.M301070200","volume":"278","author":"MI Rees","year":"2003","unstructured":"Rees, M.I. et al. Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J. Biol. Chem. 278, 24688\u201324696 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFng1814_CR6","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1523\/JNEUROSCI.1184-04.2004","volume":"24","author":"K Harvey","year":"2004","unstructured":"Harvey, K. et al. The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J. Neurosci. 24, 5816\u20135826 (2004).","journal-title":"J. Neurosci."},{"key":"BFng1814_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0303-8467(97)00022-X","volume":"99","author":"MN Vergouwe","year":"1997","unstructured":"Vergouwe, M.N. et al. Hyperekplexia-like syndromes without mutations in the GLRA1 gene. Clin. Neurol. Neurosurg. 99, 172\u2013178 (1997).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"BFng1814_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0014-5793(98)01390-8","volume":"439","author":"JA Morrow","year":"1998","unstructured":"Morrow, J.A. et al. Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localisation of the gene in the human genome. FEBS Lett. 439, 334\u2013340 (1998).","journal-title":"FEBS Lett."},{"key":"BFng1814_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0896-6273(00)80901-0","volume":"25","author":"MJ Roux","year":"2000","unstructured":"Roux, M.J. & Supplisson, S. Neuronal and glial glycine transporters have different stoichiometries. Neuron 25, 373\u2013383 (2000).","journal-title":"Neuron"},{"key":"BFng1814_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tibs.2005.04.004","volume":"30","author":"V Eulenburg","year":"2005","unstructured":"Eulenburg, V., Armsen, W., Betz, H. & Gomeza, J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem. Sci. 30, 325\u2013333 (2005).","journal-title":"Trends Biochem. Sci."},{"key":"BFng1814_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-5793(02)03251-9","volume":"529","author":"S Supplisson","year":"2002","unstructured":"Supplisson, S. & Roux, M.J. Why glycine transporters have different stoichiometries. FEBS Lett. 529, 93\u2013101 (2002).","journal-title":"FEBS Lett."},{"key":"BFng1814_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2004.09.064","volume":"373","author":"L Gabernet","year":"2005","unstructured":"Gabernet, L. et al. Enhancement of the NMDA receptor function by reduction of glycine transporter 1 expression. Neurosci. Lett. 373, 79\u201384 (2005).","journal-title":"Neurosci. Lett."},{"key":"BFng1814_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0896-6273(03)00672-X","volume":"40","author":"J Gomeza","year":"2003","unstructured":"Gomeza, J. et al. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 40, 785\u2013796 (2003).","journal-title":"Neuron"},{"key":"BFng1814_CR14","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1073\/pnas.0402662101","volume":"101","author":"G Tsai","year":"2004","unstructured":"Tsai, G. et al. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc. Natl. Acad. Sci. USA 101, 8485\u20138490 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1814_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0896-6273(03)00673-1","volume":"40","author":"J Gomeza","year":"2003","unstructured":"Gomeza, J. et al. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40, 797\u2013806 (2003).","journal-title":"Neuron"},{"key":"BFng1814_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2174\/1381612003399608","volume":"6","author":"P Krogsgaard-Larsen","year":"2000","unstructured":"Krogsgaard-Larsen, P., Frolund, B. & Frydenvang, K. GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects. Curr. Pharm. Des. 6, 1193\u20131209 (2000).","journal-title":"Curr. Pharm. Des."},{"key":"BFng1814_CR17","first-page":"321","volume-title":"Psychopharmacology\u2014the Fourth Generation of Progress","author":"EL Barker","year":"1995","unstructured":"Barker, E.L. & Blakely, R.D. Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. In Psychopharmacology\u2014the Fourth Generation of Progress (eds. Bloom, F.E. & Kupfer, D.J.) 321\u2013333 (Raven, New York, 1995)."},{"key":"BFng1814_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sj.tpj.6500106","volume":"2","author":"MK Hahn","year":"2002","unstructured":"Hahn, M.K. & Blakely, R.D. Monoamine transporter gene structure an polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J. 2, 217\u2013235 (2002).","journal-title":"Pharmacogenomics J."},{"key":"BFng1814_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1124\/mol.105.011270","volume":"68","author":"MK Hahn","year":"2005","unstructured":"Hahn, M.K., Mazei-Robison, M.S. & Blakely, R.D. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol. Pharmacol. 68, 457\u2013466 (2005).","journal-title":"Mol. Pharmacol."},{"key":"BFng1814_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/978-1-4757-6376-8_6","volume":"548","author":"GB Richerson","year":"2004","unstructured":"Richerson, G.B. & Wu, Y. Role of the GABA transporter in epilepsy. Adv. Exp. Med. Biol. 548, 76\u201391 (2004).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFng1814_CR21","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1086\/340092","volume":"70","author":"KA Hahn","year":"2002","unstructured":"Hahn, K.A. et al. X-linked mental retardation with seizures and carrier manifestations is caused my mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am. J. Hum. Genet. 70, 1349\u20131356 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng1814_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1086\/422102","volume":"75","author":"EH Rosenberg","year":"2004","unstructured":"Rosenberg, E.H. et al. High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am. J. Hum. Genet. 75, 97\u2013105 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng1814_CR23","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1073\/pnas.98.4.1448","volume":"98","author":"M Horiuchi","year":"2001","unstructured":"Horiuchi, M. et al. Surface-localized glycine transporters 1 and 2 function as monomeric proteins in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 98, 1448\u20131453 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1814_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature03978","volume":"437","author":"A Yamashita","year":"2005","unstructured":"Yamashita, A., Singh, S.K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+\/Cl\u2212-dependent neurotransmitter transporters. Nature 437, 215\u2013223 (2005).","journal-title":"Nature"},{"key":"BFng1814_CR25","doi-asserted-by":"publisher","first-page":"17699","DOI":"10.1074\/jbc.M009196200","volume":"276","author":"MJ Roux","year":"2001","unstructured":"Roux, M.J. et al. The glial and the neuronal glycine transporters differ in their reactivity to sulfhydryl reagents. J. Biol. Chem. 276, 17699\u201317705 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFng1814_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0896-6273(93)90309-F","volume":"10","author":"S Mager","year":"1993","unstructured":"Mager, S. et al. Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes. Neuron 10, 177\u2013188 (1993).","journal-title":"Neuron"},{"key":"BFng1814_CR27","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1523\/JNEUROSCI.16-17-05405.1996","volume":"16","author":"S Mager","year":"1996","unstructured":"Mager, S. et al. Ion binding and permeation at the GABA transporter GAT1. J. Neurosci. 16, 5405\u20135414 (1996).","journal-title":"J. Neurosci."},{"key":"BFng1814_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.mcn.2004.04.007","volume":"26","author":"K Ohno","year":"2004","unstructured":"Ohno, K. et al. The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Mol. Cell. Neurosci. 26, 518\u2013529 (2004).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFng1814_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1471-4159.2005.03198.x","volume":"94","author":"M Horiuchi","year":"2005","unstructured":"Horiuchi, M., Loebrich, S., Brandstaetter, J.H., Kneussel, M. & Betz, H. Cellular localization and subcellular distribution of Unc-33-like protein 6, a brain-specific protein of the collapsing response mediator protein family that interacts with the neuronal glycine transporter 2. J. Neurochem. 94, 307\u2013315 (2005).","journal-title":"J. Neurochem."},{"key":"BFng1814_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/BF02255994","volume":"10","author":"G Tunnicliff","year":"2003","unstructured":"Tunnicliff, G. Membrane glycine transport proteins. J. Biomed. Sci. 10, 30\u201336 (2003).","journal-title":"J. Biomed. Sci."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1814","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:11:50Z","timestamp":1684433510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,4]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["BFng1814"],"URL":"https:\/\/doi.org\/10.1038\/ng1814","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,4]]}}}